International HapMap Consortium publishes scientific strategy

BETHESDA, Md., Dec. 18, 2003 The International HapMap Consortium today published a paper that sets forth the scientific rationale and strategy behind its effort to create a map of human genetic variation. This genetic variation influences our individual predispositions to disease and our responses to medicines. The map is aimed at speeding the searches for genes affecting cancer, diabetes, heart disease and many other common conditions.

In the paper published in the journal Nature, the public-private consortium also outlined its policies for the rapid release of HapMap data to researchers around the world. Some of the data are being released quickly and publicly with no conditions, while some data can be accessed quickly by researchers who agree not to restrict the use of the data by other researchers, and to share the data only with those who have agreed to the same conditions.

The $120 million International HapMap Project was launched in October 2002 and is expected to take three years to complete. The project is a partnership of scientists and funding agencies from Canada, China, Japan, Nigeria, the United Kingdom and the United States. The U.S. component of the International HapMap Project is led by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health, an agency of the Department of Health and Human Services.

The goal of the consortium is to develop a public resource a map of the common patterns of human genetic variations, or haplotypes that will help researchers find genes associated with human disease and response to medicines. In addition to the current paper detailing the project's scientific strategy, the consortium plans to publish a companion paper describing in more detail how the project is addressing the ethical, social and cultural concerns raised by this type of genomics research.


Contact: Geoff Spencer
NIH/National Human Genome Research Institute

Page: 1

Related biology news :

1. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
2. USAID, Conservation International & Starbucks launch Conservation Coffee Alliance in Central America
3. ConocoPhillips & Conservation International launch Biodiversity Action Plan in Venezuela
4. A room with a view for the International Space Station: Completion of the cupola observation module
5. International symposium on nutritional genomics
6. First International Scientific Conference on Childhood Leukaemia
7. 1st International Conference on Cell Therapy for Cardiovascular Disease
8. International research conferences at the Villa Vigoni
9. Conservation International & SC Johnson invest in Ecuadors rainforest to offset climate impacts
10. STN International launches Derwent World Patents Index First View
11. Media invited to attend International Society For Heart & Lung Transplantation meeting April 21-24

Post Your Comments:

(Date:5/30/2020)... , ... May 29, 2020 , ... ... digital transformation for enterprises globally, has collaborated with EchoNous Inc. to develop the ... It can measure systolic heart function, which has been clinically tested versus expert ...
(Date:5/28/2020)... ... May 28, 2020 , ... Actuate Therapeutics, ... their 1801 Phase 1/2 study (NCT03678883, EudraCT #: 2018-003739-32) will be presented at ... place virtually on May 29th, 2020. Dr. Benedito Carneiro, Brown University’s principal investigator ...
(Date:5/21/2020)... (PRWEB) , ... May 19, ... ... the leading software-as-a-service (SaaS) provider of operations management solutions, today introduced BioMed ... module provides a cloud-based platform for connecting the people and systems around ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... ... June 30, 2020 , ... ... that the launch of a new clinical diagnostics immuno-oncology service, TissueInsight ... microenvironment (TME). , “Flagship’s TissueInsight is a service that aids pathologists, oncologists, ...
(Date:6/28/2020)... ... June 26, 2020 , ... ... solutions providers, today announced its strong opposition to the recently introduced bicameral ... a blanket ban on most federal use of nearly all biometric and related ...
(Date:6/23/2020)... , ... June 22, 2020 , ... ... glutamine antagonist, DRP-104, will be presented June 22-24 during the American Association for ... DRP-104; and, the other profiles the potent, consistent single agent activity in KEAP1 ...
(Date:6/11/2020)... ... June 09, 2020 , ... ... of a Small Business Innovation Research (SBIR) program funded by the National Institute ... Toxin Detection in the Field”. The project’s goal was to engineer and develop ...
Breaking Biology Technology:
Cached News: